• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Justice Dept. recoups $6B in False Claims Act cases

Justice Dept. recoups $6B in False Claims Act cases

November 21, 2014 By Brad Perriello

Justice Dept. recoups $6B in False Claims Act cases

The U.S. Justice Dept. said it recouped a record $5.69 billion in settlements and judgments from False Claims Act cases during the fiscal year ended Sept. 30, including some $2.3 billion in recoveries from healthcare cases.

It’s the 1st time FCA cases have exceeded the $5 billion mark, the Justice Dept. said, noting that it’s recovered $22.75 billion in FCA cases since January 2009 – nearly half of all recoveries logged since the act was amended 28 years ago.

"In the past 3 years, we have achieved the 2 largest annual recoveries ever recorded under the statute," acting associate attorney general Stuart Delery said in prepared remarks. "This sustained success demonstrates that these figures result not only from large individual matters, but from a continuous commitment year after year to pursue those who defraud taxpayers and to remain vigilant in identifying those who would unlawfully obtain money from the federal fisc."

The recoveries included a $30 million settlement from Boston Scientific (NYSE:BSX) to settle a False Claims Act lawsuit filed over pacemakers made by its star-crossed Guidant subsidiary. The lawsuit, filed in 2008 by James Allen, accused Guidant of making false claims about the defibrillators between 2002 and 2005. Guidant continued to sell the devices even though it knew of their flaws, according to the Justice Dept. Guidant paid $296 million and pleaded guilty in 2010 to criminal charges that it deliberately concealed the defects.

"Medicare patients who depend on cardiac defibrillators should not have to worry about whether their devices will work when they are needed," Delery said at the time. "This settlement, along with the prior criminal prosecution of Guidant, demonstrates that there will be significant consequences when companies engage in conduct that threatens health and safety and violates the law."

It’s the 5th year in a row that the Justice Dept. has collected more than $2 billion in healthcare FCA cases, according to a press release.

The agency said there were more than 700 qui tam whistleblower suit filed during fiscal 2014. Recoveries from whistleblower lawsuits reached nearly $3 billion; the whistleblowers themselves received $435 million, according to the release.

The Justice Dept. also cited a pair of cases involving hospitals in Kentucky, King’s Daughters Medical Center and Saint Joseph Health System, that allegedly billed Medicare and Medicaid for unnecessary coronary procedures.

King’s Daughters paid $39 million in federal claims and $2 million in state Medicaid claims to settle the allegations involving coronary stents and diagnostic catheterizations and prohibited financial relationships with referring physicians, the DoJ said.

 St. Joseph’s paid $16 million in federal claims and $366,000 in state Medicaid claims to settle allegations that it billed Medicare and Medicaid for "numerous" unnecessary invasive cardiac procedures including stents, pacemakers, coronary artery bypass graft surgeries and diagnostic catheterizations, according to the department.

Filed Under: Cardiovascular, Legal News, News Well Tagged With: Boston Scientific, U.S. Justice Dept. (DOJ)

More recent news

  • Intuitive draws on data from 14M cases to back da Vinci systems
  • Ropca wins FDA clearance for ultrasound automation systems
  • Zimmer Biomet lets go of former Nevro CEO amid leadership restructuring
  • Petal Surgical says its first-in-human incisionless surgery is coming soon and offers a first glimpse of its system
  • Philips names C-level tech execs, including new chief AI officer role

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy